APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biopharmaceutical CRO

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Biopharmaceutical CRO Market Outlook and Growth Opportunities 2026

3 May 2026194 pages

Choose your research edition.

Industry ResearchBiopharmaceutical CRO Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Biopharmaceutical CRO Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Biopharmaceutical CRO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biopharmaceutical CRO Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Biopharmaceutical CRO Market Analysis and Forecast 2026-2032223 pages · $4,950 USD

Market perspective

The global Biopharmaceutical CRO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biopharmaceutical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biopharmaceutical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biopharmaceutical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biopharmaceutical CRO market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biopharmaceutical CRO market include WuXi AppTec, WuXi Biologics, Hangzhou Tigermed, Pharmaron Beijing, ICON, PPD, BioPharma Services, TriStar Technology Group and Fortrea, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Biopharmaceutical CRO market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biopharmaceutical CRO and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biopharmaceutical CRO revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biopharmaceutical CRO market.

Biopharmaceutical CRO Segment by Company

WuXi AppTec

WuXi Biologics

Hangzhou Tigermed

Pharmaron Beijing

ICON

PPD

BioPharma Services

TriStar Technology Group

Fortrea

Eurofins BioPharma Services

Medicilon

Asymchem

UBC

SanaClis

TFS HealthScience

Parexel

Biopharmaceutical CRO Segment by Type

Full-service CRO

Specialized CRO

Biopharmaceutical CRO Segment by Application

SMBs

Large Enterprises

Biopharmaceutical CRO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biopharmaceutical CRO status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Biopharmaceutical CRO key companies, revenue, market share, and recent developments.

3. To split the Biopharmaceutical CRO breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Biopharmaceutical CRO market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biopharmaceutical CRO significant trends, drivers, influence factors in global and regions.

6. To analyze Biopharmaceutical CRO competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical CRO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical CRO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical CRO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biopharmaceutical CRO industry.

Chapter 3: Detailed analysis of Biopharmaceutical CRO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Biopharmaceutical CRO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Biopharmaceutical CRO in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biopharmaceutical CRO Industry Trends Table 2. Biopharmaceutical CRO Industry Drivers Table 3. Biopharmaceutical CRO Industry Opportunities and Challenges Table 4. Biopharmaceutical CRO Industry Restraints Table 5. Global Biopharmaceutical CRO Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biopharmaceutical CRO Revenue Share by Company (2021-2026) Table 7. Global Biopharmaceutical CRO Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Biopharmaceutical CRO Key Company Manufacturing Base & Headquarters Table 9. Global Biopharmaceutical CRO Company, Product Type & Application Table 10. Global Biopharmaceutical CRO Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Biopharmaceutical CRO by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Full-service CRO Table 15. Significant Companies of Specialized CRO Table 16. Global Biopharmaceutical CRO Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Biopharmaceutical CRO Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Biopharmaceutical CRO Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Biopharmaceutical CRO Sales Value Share by Type (2021-2026) Table 20. Global Biopharmaceutical CRO Sales Value Share by Type (2027-2032) Table 21. Significant Companies of SMBs Table 22. Significant Companies of Large Enterprises Table 23. Global Biopharmaceutical CRO Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Biopharmaceutical CRO Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Biopharmaceutical CRO Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Biopharmaceutical CRO Sales Value Share by Application (2021-2026) Table 27. Global Biopharmaceutical CRO Sales Value Share by Application (2027-2032) Table 28. Global Biopharmaceutical CRO Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Biopharmaceutical CRO Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Biopharmaceutical CRO Sales Value Share by Region (2021-2026) Table 31. Global Biopharmaceutical CRO Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Biopharmaceutical CRO Sales Value Share by Region (2027-2032) Table 33. Global Biopharmaceutical CRO Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Biopharmaceutical CRO Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Biopharmaceutical CRO Sales Value Market Share by Country (2021-2026) Table 36. Global Biopharmaceutical CRO Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Biopharmaceutical CRO Sales Value Market Share by Country (2027-2032) Table 38. WuXi AppTec Company Information Table 39. WuXi AppTec Business Overview Table 40. WuXi AppTec Biopharmaceutical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. WuXi AppTec Biopharmaceutical CRO Product Portfolio Table 42. WuXi AppTec Recent Development Table 43. WuXi Biologics Company Information Table 44. WuXi Biologics Business Overview Table 45. WuXi Biologics Biopharmaceutical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. WuXi Biologics Biopharmaceutical CRO Product Portfolio Table 47. WuXi Biologics Recent Development Table 48. Hangzhou Tigermed Company Information Table 49. Hangzhou Tigermed Business Overview Table 50. Hangzhou Tigermed Biopharmaceutical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Hangzhou Tigermed Biopharmaceutical CRO Product Portfolio Table 52. Hangzhou Tigermed Recent Development Table 53. Pharmaron Beijing Company Information Table 54. Pharmaron Beijing Business Overview Table 55. Pharmaron Beijing Biopharmaceutical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Pharmaron Beijing Biopharmaceutical CRO Product Portfolio Table 57. Pharmaron Beijing Recent Development Table 58. ICON Company Information Table 59. ICON Business Overview Table 60. ICON Biopharmaceutical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. ICON Biopharmaceutical CRO Product Portfolio Table 62. ICON Recent Development Table 63. PPD Company Information Table 64. PPD Business Overview Table 65. PPD Biopharmaceutical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. PPD Biopharmaceutical CRO Product Portfolio Table 67. PPD Recent Development Table 68. BioPharma Services Company Information Table 69. BioPharma Services Business Overview Table 70. BioPharma Services Biopharmaceutical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. BioPharma Services Biopharmaceutical CRO Product Portfolio Table 72. BioPharma Services Recent Development Table 73. TriStar Technology Group Company Information Table 74. TriStar Technology Group Business Overview Table 75. TriStar Technology Group Biopharmaceutical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. TriStar Technology Group Biopharmaceutical CRO Product Portfolio Table 77. TriStar Technology Group Recent Development Table 78. Fortrea Company Information Table 79. Fortrea Business Overview Table 80. Fortrea Biopharmaceutical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Fortrea Biopharmaceutical CRO Product Portfolio Table 82. Fortrea Recent Development Table 83. Eurofins BioPharma Services Company Information Table 84. Eurofins BioPharma Services Business Overview Table 85. Eurofins BioPharma Services Biopharmaceutical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Eurofins BioPharma Services Biopharmaceutical CRO Product Portfolio Table 87. Eurofins BioPharma Services Recent Development Table 88. Medicilon Company Information Table 89. Medicilon Business Overview Table 90. Medicilon Biopharmaceutical CRO Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Medicilon Biopharmaceutical CRO Product Portfolio Table 92. Medicilon Recent Development Table 93. Asymchem Company Information Table 94. Asymchem Business Overview Table 95. Asymchem Biopharmaceutical CRO Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Asymchem Biopharmaceutical CRO Product Portfolio Table 97. Asymchem Recent Development Table 98. UBC Company Information Table 99. UBC Business Overview Table 100. UBC Biopharmaceutical CRO Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. UBC Biopharmaceutical CRO Product Portfolio Table 102. UBC Recent Development Table 103. SanaClis Company Information Table 104. SanaClis Business Overview Table 105. SanaClis Biopharmaceutical CRO Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. SanaClis Biopharmaceutical CRO Product Portfolio Table 107. SanaClis Recent Development Table 108. TFS HealthScience Company Information Table 109. TFS HealthScience Business Overview Table 110. TFS HealthScience Biopharmaceutical CRO Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. TFS HealthScience Biopharmaceutical CRO Product Portfolio Table 112. TFS HealthScience Recent Development Table 113. Parexel Company Information Table 114. Parexel Business Overview Table 115. Parexel Biopharmaceutical CRO Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Parexel Biopharmaceutical CRO Product Portfolio Table 117. Parexel Recent Development Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Biopharmaceutical CRO Product Image Figure 2. Global Biopharmaceutical CRO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 4. Global Biopharmaceutical CRO Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Full-service CRO Image Figure 8. Specialized CRO Image Figure 9. Global Biopharmaceutical CRO Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Biopharmaceutical CRO Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Biopharmaceutical CRO Sales Value Share by Type (2021-2032) Figure 12. SMBs Image Figure 13. Large Enterprises Image Figure 14. Global Biopharmaceutical CRO Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Biopharmaceutical CRO Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Biopharmaceutical CRO Sales Value Share by Application (2021-2032) Figure 17. Global Biopharmaceutical CRO Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Biopharmaceutical CRO Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Biopharmaceutical CRO Sales Value (2021-2032) & (US$ Million) Figure 20. North America Biopharmaceutical CRO Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Biopharmaceutical CRO Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Biopharmaceutical CRO Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Biopharmaceutical CRO Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Biopharmaceutical CRO Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Biopharmaceutical CRO Sales Value (2021-2032) & (US$ Million) Figure 26. South America Biopharmaceutical CRO Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Biopharmaceutical CRO Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Biopharmaceutical CRO Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Biopharmaceutical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Full-service CRO
  • Specialized CRO
Applications
  • SMBs
  • Large Enterprises
Companies covered
  • WuXi AppTec
  • WuXi Biologics
  • Hangzhou Tigermed
  • Pharmaron Beijing
  • ICON
  • PPD
  • BioPharma Services
  • TriStar Technology Group
  • Fortrea
  • Eurofins BioPharma Services
  • Medicilon
  • Asymchem
  • UBC
  • SanaClis
  • TFS HealthScience
  • Parexel

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biopharmaceutical CRO Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biopharmaceutical CRO Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Biopharmaceutical CRO Market Dynamics
  1. 2.1 Biopharmaceutical CRO Industry Trends
  2. 2.2 Biopharmaceutical CRO Industry Drivers
  3. 2.3 Biopharmaceutical CRO Industry Opportunities and Challenges
  4. 2.4 Biopharmaceutical CRO Industry Restraints
3 Biopharmaceutical CRO Market by Company
  1. 3.1 Global Biopharmaceutical CRO Company Revenue Ranking in 2025
  2. 3.2 Global Biopharmaceutical CRO Revenue by Company (2021-2026)
  3. 3.3 Global Biopharmaceutical CRO Company Ranking (2024-2026)
  4. 3.4 Global Biopharmaceutical CRO Company Manufacturing Base and Headquarters
  5. 3.5 Global Biopharmaceutical CRO Company Product Type and Application
  6. 3.6 Global Biopharmaceutical CRO Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Biopharmaceutical CRO Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Biopharmaceutical CRO Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Biopharmaceutical CRO Market by Type
  1. 4.1 Biopharmaceutical CRO Type Introduction
  2. 4.1.1 Full-service CRO
  3. 4.1.2 Specialized CRO
  4. 4.2 Global Biopharmaceutical CRO Sales Value by Type
  5. 4.2.1 Global Biopharmaceutical CRO Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Biopharmaceutical CRO Sales Value by Type (2021-2032)
  7. 4.2.3 Global Biopharmaceutical CRO Sales Value Share by Type (2021-2032)
5 Biopharmaceutical CRO Market by Application
  1. 5.1 Biopharmaceutical CRO Application Introduction
  2. 5.1.1 SMBs
  3. 5.1.2 Large Enterprises
  4. 5.2 Global Biopharmaceutical CRO Sales Value by Application
  5. 5.2.1 Global Biopharmaceutical CRO Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Biopharmaceutical CRO Sales Value by Application (2021-2032)
  7. 5.2.3 Global Biopharmaceutical CRO Sales Value Share by Application (2021-2032)
6 Biopharmaceutical CRO Regional Value Analysis
  1. 6.1 Global Biopharmaceutical CRO Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biopharmaceutical CRO Sales Value by Region (2021-2032)
  3. 6.2.1 Global Biopharmaceutical CRO Sales Value by Region: 2021-2026
  4. 6.2.2 Global Biopharmaceutical CRO Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biopharmaceutical CRO Sales Value (2021-2032)
  7. 6.3.2 North America Biopharmaceutical CRO Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Biopharmaceutical CRO Sales Value (2021-2032)
  10. 6.4.2 Europe Biopharmaceutical CRO Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Biopharmaceutical CRO Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Biopharmaceutical CRO Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Biopharmaceutical CRO Sales Value (2021-2032)
  16. 6.6.2 South America Biopharmaceutical CRO Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Biopharmaceutical CRO Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Biopharmaceutical CRO Sales Value Share by Country, 2025 VS 2032
7 Biopharmaceutical CRO Country-level Value Analysis
  1. 7.1 Global Biopharmaceutical CRO Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biopharmaceutical CRO Sales Value by Country (2021-2032)
  3. 7.2.1 Global Biopharmaceutical CRO Sales Value by Country (2021-2026)
  4. 7.2.2 Global Biopharmaceutical CRO Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Biopharmaceutical CRO Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Biopharmaceutical CRO Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Biopharmaceutical CRO Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 WuXi AppTec
  2. 8.1.1 WuXi AppTec Company Information
  3. 8.1.2 WuXi AppTec Business Overview
  4. 8.1.3 WuXi AppTec Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  5. 8.1.4 WuXi AppTec Biopharmaceutical CRO Product Portfolio
  6. 8.1.5 WuXi AppTec Recent Developments
  7. 8.2 WuXi Biologics
  8. 8.2.1 WuXi Biologics Company Information
  9. 8.2.2 WuXi Biologics Business Overview
  10. 8.2.3 WuXi Biologics Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  11. 8.2.4 WuXi Biologics Biopharmaceutical CRO Product Portfolio
  12. 8.2.5 WuXi Biologics Recent Developments
  13. 8.3 Hangzhou Tigermed
  14. 8.3.1 Hangzhou Tigermed Company Information
  15. 8.3.2 Hangzhou Tigermed Business Overview
  16. 8.3.3 Hangzhou Tigermed Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hangzhou Tigermed Biopharmaceutical CRO Product Portfolio
  18. 8.3.5 Hangzhou Tigermed Recent Developments
  19. 8.4 Pharmaron Beijing
  20. 8.4.1 Pharmaron Beijing Company Information
  21. 8.4.2 Pharmaron Beijing Business Overview
  22. 8.4.3 Pharmaron Beijing Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pharmaron Beijing Biopharmaceutical CRO Product Portfolio
  24. 8.4.5 Pharmaron Beijing Recent Developments
  25. 8.5 ICON
  26. 8.5.1 ICON Company Information
  27. 8.5.2 ICON Business Overview
  28. 8.5.3 ICON Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ICON Biopharmaceutical CRO Product Portfolio
  30. 8.5.5 ICON Recent Developments
  31. 8.6 PPD
  32. 8.6.1 PPD Company Information
  33. 8.6.2 PPD Business Overview
  34. 8.6.3 PPD Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PPD Biopharmaceutical CRO Product Portfolio
  36. 8.6.5 PPD Recent Developments
  37. 8.7 BioPharma Services
  38. 8.7.1 BioPharma Services Company Information
  39. 8.7.2 BioPharma Services Business Overview
  40. 8.7.3 BioPharma Services Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BioPharma Services Biopharmaceutical CRO Product Portfolio
  42. 8.7.5 BioPharma Services Recent Developments
  43. 8.8 TriStar Technology Group
  44. 8.8.1 TriStar Technology Group Company Information
  45. 8.8.2 TriStar Technology Group Business Overview
  46. 8.8.3 TriStar Technology Group Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  47. 8.8.4 TriStar Technology Group Biopharmaceutical CRO Product Portfolio
  48. 8.8.5 TriStar Technology Group Recent Developments
  49. 8.9 Fortrea
  50. 8.9.1 Fortrea Company Information
  51. 8.9.2 Fortrea Business Overview
  52. 8.9.3 Fortrea Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Fortrea Biopharmaceutical CRO Product Portfolio
  54. 8.9.5 Fortrea Recent Developments
  55. 8.10 Eurofins BioPharma Services
  56. 8.10.1 Eurofins BioPharma Services Company Information
  57. 8.10.2 Eurofins BioPharma Services Business Overview
  58. 8.10.3 Eurofins BioPharma Services Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Eurofins BioPharma Services Biopharmaceutical CRO Product Portfolio
  60. 8.10.5 Eurofins BioPharma Services Recent Developments
  61. 8.11 Medicilon
  62. 8.11.1 Medicilon Company Information
  63. 8.11.2 Medicilon Business Overview
  64. 8.11.3 Medicilon Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Medicilon Biopharmaceutical CRO Product Portfolio
  66. 8.11.5 Medicilon Recent Developments
  67. 8.12 Asymchem
  68. 8.12.1 Asymchem Company Information
  69. 8.12.2 Asymchem Business Overview
  70. 8.12.3 Asymchem Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Asymchem Biopharmaceutical CRO Product Portfolio
  72. 8.12.5 Asymchem Recent Developments
  73. 8.13 UBC
  74. 8.13.1 UBC Company Information
  75. 8.13.2 UBC Business Overview
  76. 8.13.3 UBC Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  77. 8.13.4 UBC Biopharmaceutical CRO Product Portfolio
  78. 8.13.5 UBC Recent Developments
  79. 8.14 SanaClis
  80. 8.14.1 SanaClis Company Information
  81. 8.14.2 SanaClis Business Overview
  82. 8.14.3 SanaClis Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  83. 8.14.4 SanaClis Biopharmaceutical CRO Product Portfolio
  84. 8.14.5 SanaClis Recent Developments
  85. 8.15 TFS HealthScience
  86. 8.15.1 TFS HealthScience Company Information
  87. 8.15.2 TFS HealthScience Business Overview
  88. 8.15.3 TFS HealthScience Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  89. 8.15.4 TFS HealthScience Biopharmaceutical CRO Product Portfolio
  90. 8.15.5 TFS HealthScience Recent Developments
  91. 8.16 Parexel
  92. 8.16.1 Parexel Company Information
  93. 8.16.2 Parexel Business Overview
  94. 8.16.3 Parexel Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Parexel Biopharmaceutical CRO Product Portfolio
  96. 8.16.5 Parexel Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst